EP1379651A2 - Genes humains et produits d'expression genetique isoles de la prostate humaine - Google Patents

Genes humains et produits d'expression genetique isoles de la prostate humaine

Info

Publication number
EP1379651A2
EP1379651A2 EP01989188A EP01989188A EP1379651A2 EP 1379651 A2 EP1379651 A2 EP 1379651A2 EP 01989188 A EP01989188 A EP 01989188A EP 01989188 A EP01989188 A EP 01989188A EP 1379651 A2 EP1379651 A2 EP 1379651A2
Authority
EP
European Patent Office
Prior art keywords
sep
sequence
seq
polynucleotide
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01989188A
Other languages
German (de)
English (en)
Inventor
Jaime Escobedo
Pablo Dominguez Garcia
Altaf Kassam
George Lamson
Radoje Drmanac
Radomir Crkvenjakov
Mark Dickson
Snezana Drmanac
Ivan Labat
Dena Leshkowitz
David Kita
Veronica Garcia
William Lee Jones
Birgit Stache-Crain
Elizabeth M. Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Nuvelo Inc
Original Assignee
Hyseq Inc
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Chiron Corp filed Critical Hyseq Inc
Publication of EP1379651A2 publication Critical patent/EP1379651A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne de nouveaux polynucléotides humains et des variants de ceux-ci, leurs polypeptides codés et les variants de ceux-ci, des gènes correspondant à ces polynucléotides et des protéines exprimées par ces gènes. L'invention concerne également des diagnostics et thérapies utilisant ces nouveaux polynucléotides humains, leurs gènes correspondants ou leurs produits génétiques, y compris des sondes, des nucléotides antisens et des anticorps. Les polynucléotides décrits par la présente invention correspondent à un polynucléotide contenant les informations de séquence d'au moins une des SEQ ID NOS:1-1477. Les polypeptides décrits par la présente invention correspondent à un polypeptide comprenant des informations de séquence aminoacide d'au moins une des séquences SEQ ID NOS:1478-1568.
EP01989188A 2000-12-07 2001-12-07 Genes humains et produits d'expression genetique isoles de la prostate humaine Withdrawn EP1379651A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25464800P 2000-12-07 2000-12-07
US254648P 2000-12-07
US27568801P 2001-03-13 2001-03-13
US275688P 2001-03-13
PCT/US2001/047349 WO2002055700A2 (fr) 2000-12-07 2001-12-07 Genes humains et produits d'expression genetique isoles de la prostate humaine

Publications (1)

Publication Number Publication Date
EP1379651A2 true EP1379651A2 (fr) 2004-01-14

Family

ID=26944174

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01989188A Withdrawn EP1379651A2 (fr) 2000-12-07 2001-12-07 Genes humains et produits d'expression genetique isoles de la prostate humaine

Country Status (5)

Country Link
EP (1) EP1379651A2 (fr)
JP (1) JP2004526429A (fr)
AU (1) AU2002243300A1 (fr)
CA (1) CA2430794A1 (fr)
WO (1) WO2002055700A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215803A1 (en) * 2000-12-07 2003-11-20 Garcia Pablo Dominguez Human genes and gene expression products isolated from human prostate
WO2002060953A2 (fr) 2000-12-15 2002-08-08 Agensys, Inc. Acide nucleique et proteine transporteur de zinc codee intitules 108p5h8 utiles dans le traitement et la detection du cancer
US8647826B2 (en) 2001-03-14 2014-02-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2005080562A1 (fr) * 2004-02-23 2005-09-01 Hiroshi Yamamoto Procédé consistant à se prononcer sur un cancer de la prostate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US6476207B1 (en) * 1998-06-11 2002-11-05 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO02055700A2 *

Also Published As

Publication number Publication date
AU2002243300A1 (en) 2002-07-24
WO2002055700A2 (fr) 2002-07-18
CA2430794A1 (fr) 2002-07-18
WO2002055700A3 (fr) 2003-10-23
WO2002055700A8 (fr) 2005-01-06
JP2004526429A (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
US7122373B1 (en) Human genes and gene expression products V
US20070243176A1 (en) Human genes and gene expression products
US8101349B2 (en) Gene products differentially expressed in cancerous cells and their methods of use II
EP2300041B1 (fr) Méthode pour déterminer le risque du récidive du cancer de la prostate
JP2003518920A (ja) 新規なヒト遺伝子および遺伝子発現産物
US20110288034A1 (en) Methods of identifying adipocyte specific genes, the genes identified, and their uses
WO2001066753A2 (fr) Nouveaux genes humains et leurs produits d'expression
US20020076735A1 (en) Diagnostic and therapeutic methods using molecules differentially expressed in cancer cells
JP2002500010A (ja) ヒト遺伝子および遺伝子発現産物ｉ
US20030215803A1 (en) Human genes and gene expression products isolated from human prostate
JP2011254830A (ja) 結腸癌に関するポリヌクレオチド
US20030065156A1 (en) Novel human genes and gene expression products I
EP1379651A2 (fr) Genes humains et produits d'expression genetique isoles de la prostate humaine
WO2000018916A2 (fr) Genes humains et produits d'expression genique
EP1268528A2 (fr) Genes humaines et produits d'expression
US20060122132A1 (en) Use of murine genomic regions identified to be involved in tumor developement for the development of anti-cancer drugs and diagnosis of cancer
WO2004039943A2 (fr) Genes humains et produits de l'expression genique isoles de la prostate humaine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030626

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

Owner name: CHIRON CORPORATION

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060221